You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR TROKENDI XR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for TROKENDI XR

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03280342 ↗ Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine Withdrawn Supernus Pharmaceuticals, Inc. Phase 2 2017-10-30 Crossover, randomized, double blind: Q12h dosing in both periods; matching placebo for evening dosing during XR treatment; target dose: 100mg
NCT03280342 ↗ Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine Withdrawn University of Minnesota Phase 2 2017-10-30 Crossover, randomized, double blind: Q12h dosing in both periods; matching placebo for evening dosing during XR treatment; target dose: 100mg
NCT03280342 ↗ Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine Withdrawn University of Minnesota - Clinical and Translational Science Institute Phase 2 2017-10-30 Crossover, randomized, double blind: Q12h dosing in both periods; matching placebo for evening dosing during XR treatment; target dose: 100mg
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for TROKENDI XR

Condition Name

Condition Name for TROKENDI XR
Intervention Trials
Headache 1
Migraine 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for TROKENDI XR
Intervention Trials
Migraine Disorders 1
Headache 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TROKENDI XR

Trials by Country

Trials by Country for TROKENDI XR
Location Trials
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for TROKENDI XR
Location Trials
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TROKENDI XR

Clinical Trial Phase

Clinical Trial Phase for TROKENDI XR
Clinical Trial Phase Trials
Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for TROKENDI XR
Clinical Trial Phase Trials
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TROKENDI XR

Sponsor Name

Sponsor Name for TROKENDI XR
Sponsor Trials
Supernus Pharmaceuticals, Inc. 1
University of Minnesota 1
University of Minnesota - Clinical and Translational Science Institute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for TROKENDI XR
Sponsor Trials
Other 2
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.